Diagnostics (Feb 2021)

The Emerging Role of Small Extracellular Vesicles in Inflammatory Airway Diseases

  • Katarzyna Piszczatowska,
  • Katarzyna Czerwaty,
  • Anna M. Cyran,
  • Mathias Fiedler,
  • Nils Ludwig,
  • Jacek Brzost,
  • Mirosław J. Szczepański

DOI
https://doi.org/10.3390/diagnostics11020222
Journal volume & issue
Vol. 11, no. 2
p. 222

Abstract

Read online

Extracellular vesicles (EVs) are produced and released by all cells and are present in all body fluids. They exist in a variety of sizes, however, small extracellular vesicles (sEVs), the EV subset with a size range from 30 to 150 nm, are of current interest. By transporting a complex cargo that includes genetic material, proteins, lipids, and signaling molecules, sEVs can alter the state of recipient cells. The role of sEVs in mediating inflammatory processes and responses of the immune system is well-documented, and adds another layer of complexity to our understanding of frequent diseases, including chronic rhinosinusitis (CRS), asthma, chronic obstructive pulmonary disease (COPD), and upper airway infections. In these diseases, two aspects of sEV biology are of particular interest: (1) sEVs might be involved in the etiopathogenesis of inflammatory airway diseases, and might emerge as attractive therapeutic targets, and (2) sEVs might be of diagnostic or prognostic relevance. The purpose of this review is to outline the biological functions of sEVs and their capacity to both augment and attenuate inflammation and immune response in the context of pathogen invasion, CRS, asthma, and COPD.

Keywords